Drug intelligence / Profile preview

Toraymyxin PMX-20R

Development stage
Unknown
Lead developer
Spectral Medical
Administration
Extracorporeal Hemoperfusion (through Blood Circuit, Venous Catheter)[4][5]
01

Overview

**Toraymyxin PMX-20R** is a single-use extracorporeal hemoperfusion cartridge designed for the selective removal of endotoxin from circulating blood in patients with sepsis or septic shock associated with Gram-negative bacterial infection or endotoxemia[1][2][4][5][7]. Its mechanism utilizes **polymyxin B** immobilized on polystyrene derivative fibers to adsorb and bind endotoxins, preventing their systemic effects[1][4][5][7]. While polymyxin B is a potent antibiotic, its systemic use is limited by nephrotoxicity and neurotoxicity; immobilization on the cartridge enables safe extracorporeal removal of circulating endotoxins[1][4]. The device is indicated for use alongside standard medical care in intensive care settings and requires compatible hemodialysis or continuous renal replacement therapy (CRRT) equipment[4][5]. Clinical data indicate Toraymyxin improves hemodynamics, decreases vasopressor requirements, may improve oxygenation, and can reduce organ dysfunction and mortality in septic shock patients[1][3][4][8].

Brand names
Toraymyxin PMX-20RTORAYMYXINPMX
Other names
PMX cartridgePolymyxin B-immobilized fiber columnToraymyxinPMX-20R columnPMX20R columnPMX 20R column
02

Targets

MIF (Oxidized macrophage migration inhibitory factor)LTA (Lymphotoxin-alpha)

Beyond the preview

Go deeper on Toraymyxin PMX-20R.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toraymyxin PMX-20R.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call